MiR-133a exhibits the potential to induce cellular apoptosis and suppress cell proliferation in NSCLC cells, a process facilitated by its specific targeting of the EGFR/AKT/ERK signaling pathway [29]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.